ERDEM, Hakan, Yasemin CAG, Derya OZTURK-ENGIN, Sylviane DEFRES, Selcuk KAYA, Lykke LARSEN, Mario POLJAK, Bruno BARSIC, Xavier ARGEMI, Signe Maj SØRENSEN, Anne Lisbeth BOHR, Pierre TATTEVIN, Jesper Damsgaard GUNST, Lenka BAŠTÁKOVÁ, Matjaž JEREB, Isik Somuncu JOHANSEN, Oguz KARABAY, Abdullah Umut PEKOK, Oguz Resat SIPAHI, Mahtab CHEHRI, Guillaume BERAUD, Ghaydaa SHEHATA, Rosa Fontana DEL VECCHIO, Mauro MARESCA, Hasan KARSEN, Gonul SENGOZ, Mustafa SUNBUL, Gulden YILMAZ, Hava YILMAZ, Ahmad SHARIF-YAKAN, Souha Shararah KANJ, Emine PARLAK, Filiz PEHLIVANOGLU, Fatime KORKMAZ, Suheyla KOMUR, Sukran KOSE, Mehmet ULUG, Sibel BOLUKCU, Seher Ayten COSKUNER, Nevin INCE, Yasemin AKKOYUNLU, Gulistan HALAC, Elif SAHIN-HORASAN, Hulya TIRELI, Gamze KILICOGLU, Akram AL-MANDAWI, Salih Atakan NEMLI, Asuman INAN, Seniha SENBAYRAK, Jean Paul STAHL a Haluk VAHABOGLU. Results of a Multinational Study Suggest the Need for Rapid Diagnosis and Early Antiviral Treatment at the Onset of Herpetic Meningoencephalitis. Antimicrobial Agents and Chemotherapy. Washington: American Society for Microbiology, 2015, roč. 59, č. 6, s. 3084-3089. ISSN 0066-4804. Dostupné z: https://dx.doi.org/10.1128/AAC.05016-14.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Results of a Multinational Study Suggest the Need for Rapid Diagnosis and Early Antiviral Treatment at the Onset of Herpetic Meningoencephalitis
Autoři ERDEM, Hakan (792 Turecko), Yasemin CAG (792 Turecko), Derya OZTURK-ENGIN (792 Turecko), Sylviane DEFRES (826 Velká Británie a Severní Irsko), Selcuk KAYA (792 Turecko), Lykke LARSEN (208 Dánsko), Mario POLJAK (705 Slovinsko), Bruno BARSIC (191 Chorvatsko), Xavier ARGEMI (250 Francie), Signe Maj SØRENSEN (208 Dánsko), Anne Lisbeth BOHR (208 Dánsko), Pierre TATTEVIN (250 Francie), Jesper Damsgaard GUNST (208 Dánsko), Lenka BAŠTÁKOVÁ (703 Slovensko, garant, domácí), Matjaž JEREB (705 Slovinsko), Isik Somuncu JOHANSEN (208 Dánsko), Oguz KARABAY (792 Turecko), Abdullah Umut PEKOK (792 Turecko), Oguz Resat SIPAHI (792 Turecko), Mahtab CHEHRI (208 Dánsko), Guillaume BERAUD (250 Francie), Ghaydaa SHEHATA (818 Egypt), Rosa Fontana DEL VECCHIO (380 Itálie), Mauro MARESCA (380 Itálie), Hasan KARSEN (792 Turecko), Gonul SENGOZ (792 Turecko), Mustafa SUNBUL (792 Turecko), Gulden YILMAZ (792 Turecko), Hava YILMAZ (792 Turecko), Ahmad SHARIF-YAKAN (422 Libanon), Souha Shararah KANJ (422 Libanon), Emine PARLAK (792 Turecko), Filiz PEHLIVANOGLU (792 Turecko), Fatime KORKMAZ (792 Turecko), Suheyla KOMUR (792 Turecko), Sukran KOSE (792 Turecko), Mehmet ULUG (792 Turecko), Sibel BOLUKCU (792 Turecko), Seher Ayten COSKUNER (792 Turecko), Nevin INCE (792 Turecko), Yasemin AKKOYUNLU (792 Turecko), Gulistan HALAC (792 Turecko), Elif SAHIN-HORASAN (792 Turecko), Hulya TIRELI (792 Turecko), Gamze KILICOGLU (792 Turecko), Akram AL-MANDAWI (368 Irák), Salih Atakan NEMLI (792 Turecko), Asuman INAN (792 Turecko), Seniha SENBAYRAK (792 Turecko), Jean Paul STAHL (250 Francie) a Haluk VAHABOGLU (792 Turecko).
Vydání Antimicrobial Agents and Chemotherapy, Washington, American Society for Microbiology, 2015, 0066-4804.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30300 3.3 Health sciences
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 4.415
Kód RIV RIV/00216224:14110/15:00083649
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1128/AAC.05016-14
UT WoS 000358623200015
Klíčová slova anglicky CENTRAL-NERVOUS-SYSTEM; SIMPLEX ENCEPHALITIS; BACTERIAL-MENINGITIS; PRACTICE GUIDELINES; ADULT PATIENTS; ACYCLOVIR; MANAGEMENT; INFECTIONS; MANIFESTATIONS; MULTICENTER
Štítky EL OK
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Ing. Mgr. Věra Pospíšilíková, učo 9005. Změněno: 28. 8. 2015 11:16.
Anotace
Data in the literature regarding the factors that predict unfavorable outcomes in adult herpetic meningoencephalitis (HME) cases are scarce. We conducted a multicenter study in order to provide insights into the predictors of HME outcomes, with special emphasis on the use and timing of antiviral treatment. Samples from 501 patients with molecular confirmation from cerebrospinal fluid were included from 35 referral centers in 10 countries. Four hundred thirty-eight patients were found to be eligible for the analysis. Overall, 232 (52.9%) patients experienced unfavorable outcomes, 44 died, and 188 survived, with sequelae. Age (odds ratio [OR], 1.04; 95% confidence interval [CI], 1.02 to 1.05), Glasgow Coma Scale score (OR, 0.84; 95% CI, 0.77 to 0.93), and symptomatic periods of 2 to 7 days (OR, 1.80; 95% CI, 1.16 to 2.79) and >7 days (OR, 3.75; 95% CI, 1.72 to 8.15) until the commencement of treatment predicted unfavorable outcomes. The outcome in HME patients is related to a combination of therapeutic and host factors. This study suggests that rapid diagnosis and early administration of antiviral treatment in HME patients are keys to a favorable outcome.
VytisknoutZobrazeno: 30. 7. 2024 05:22